BioPharma Pharma Research
SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane
First Generic of Abraxane in Korea, World 4th Commercial Scale-Up Global tech-transfer expected to US, Japan, and Europe Through this contr...
January 26, 2023 | News
KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced it entered into a subcontract with Mapp Biopharmaceutical, Inc. (Mapp) for the cont...
January 23, 2023 | News
Thermo Fisher Scientific Launches CE-IVD Marked Assay to Detect Treatment-Resistant Strains of HIV-1
Data derived from the test can help to serve as a critical tool to monitor and help treat HIV-1-infected individuals, as well as inform epidemiologic and g...
January 23, 2023 | News
CureSearch To Lead Impact Study On Cost, Treatment Benefits Of Molecular Testing For Childhood Cancer Patients
Cancer is the number one disease killer in children in the US. Although survival rates for the most common types of childhood cancer have greatly increased...
January 20, 2023 | News
NUS Medicine establishes the Lim Wee Chai Visiting Professorship in Medicine with gift of S$1 million
The signing ceremony cum cheque presentation between Professor Chong Yap Seng, Dean of NUS Medicine, and Tan Sri Dr. Lim Wee Chai, was held on 10 January 2...
January 13, 2023 | News
Research commenced with Keio University to discover drugs using "Chemicals Informatics
Hitachi High-Tech Solutions Corporation, in collaboration with Keio University Faculty of Pharmacy, Department of Pharmaceutical Sciences is commenci...
January 12, 2023 | News
EpiVax and Zoetis to Collaborate on Swine T cell Epitope Prediction Tool: CircoMatch™
The new tool provides a quick turnaround, powerful way to provide near real-time predictive effectiveness data so swine veterinarians and producers can mak...
January 11, 2023 | News
Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
Exelixis is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization o...
January 11, 2023 | News
Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research Collaboration
“This second collaboration with Astellas demonstrates the power of our antibody discovery capabilities. The depth and breadth of our Library of Libra...
January 10, 2023 | News
Avantor® and Catalent Enter into Multi-Year Supply and Services Agreement
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologi...
January 09, 2023 | News
Cartherics granted first patent in China for multiple development candidates
The patent provides a proprietary position for multiple development candidates in Cartherics’ pipeline. Specifically, it covers Cartherics’ chi...
January 09, 2023 | News
Agilent Announces Expansion of Portfolio With Acquisition of Avida Biomed
Innovative chemistries enable simultaneous genomic and epigenomic profiling on the same sample, yielding greater insights for precision medicine Agilent T...
January 06, 2023 | News
Helix and QIAGEN Form Exclusive Global Partnership to Develop and Commercialize Companion Diagnostics for Hereditary Diseases
Addressing health burden in neuro-degenerative diseases, cardiovascular diseases, and auto-immune and inflammatory diseases that affect hundreds of milli...
January 06, 2023 | News
Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program
Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug co...
January 04, 2023 | News
Most Read
- Industry Brief on 6 Key Capabilities of an eDHR System
- Menarini Silicon Biosystems's CELLSEARCH® CMMC and HER2-CTC Liquid Biopsy Tests obtain Reimbursement Codes with Preliminary Pricing Determination
- Modernizing Your Way to Success in Cell & Gene Therapy Manufacturing
- Univercells Technologies Completes EUR 2M Expansion of the Nivelles, Belgium Site
- Merck Boosts Commercial Capacity in France as Part of New Millipore® CTDMO Services
- Emerging Southeast pharma nations predicted to grow faster than Singapore
- Cytiva strengthens cell line development with CEVEC acquisition
Bio Jobs
- Life sciences professional Peter Marchesini joins Indegene to help clients improve commercial outcomes
- Emmes Hires Ching Tian in New Leadership Role
- ProtonDx Revs Up European Commercial Expansion with New Head of Sales
- Danaher Careers - Search Global Science and Technology Jobs
- Careers at MERCK Group
- Find your Job at Eppendorf
News
Editor Picks
